Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: A population-based study in Taiwan

Retina

Volumn 34, Issue 9, 2014, Pages 1867-1874

  Tsai, Der Chong ^a   Chen, Shih Jen ^b   Huang, Chin Chou ^a,b   Chou, Pesus ^a   Chung, Chia Min ^c   Chan, Wan Leong ^b   Huang, Po Hsun ^a,b   Lin, Shing Jong ^a,b   Chen, Jaw Wen ^a,b   Chen, Tseng Ji ^a,b   Leu, Hsin Bang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Central serous chorioretinopathy; Corticosteroids; National Health Insurance Research Database; Population based study

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; GLUCOCORTICOID;

ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA BASE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TAIWAN; AGED; CASE CONTROL STUDY; CENTRAL SEROUS CHORIORETINOPATHY; CHEMICALLY INDUCED; FACTUAL DATABASE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRESCRIPTION; PUBLIC HEALTH; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGED; CASE-CONTROL STUDIES; CENTRAL SEROUS CHORIORETINOPATHY; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 84906934556     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000159     Document Type: Article

References (26)

1. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984;68:329-331.
2. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 1997;41:180-185.
3. Chaine G, Haouat M, Menard-Molcard C. Central serous chorioretinopathy and systemic steroid therapy. J Fr Ophthalmol 2001;24:139-146.
4. Gupta SR, Suhler EB, Rosenbaum JT. The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular inflammatory disease. J Rheumatol 2010; 37:1973-1974.
5. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47:431-448.
6. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63-68.
7. Haimovici R, Koh S, Gagnon DR, et al; Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004;111:244-249.
8. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002;109:1834-1837.
9. Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, casecontrol study. Graefes Arch Clin Exp Ophthalmol 2004;242: 800-802.
10. Friberg TR, Eller AW. Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefes Arch Clin Exp Ophthalmol 1990;228:305-309.
11. Jabs DA, Hanneken AM, Schachat AP, Fine SL. Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol 1988; 106:230-234.
12. Haynes RC. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, Taylor AP, eds. The Pharmacological Basic of Therapeutics. 8th ed. New York, NY: Pergamon Press; 1990: 1431-1462.
13. Kitzmann AS, Pulido JS, Diehl NN, et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 2008;115:169-173.
14. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 1987;7:111-131.
15. Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996; 103:2070-2079.
16. Leveque TK, Yu L, Musch DC, et al. Central serous chorioretinopathy and risk for obstructive sleep apnea. Sleep Breath 2007;11:253-257.
17. Tsai DC, Chen SJ, Huang CC, et al. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study. PLoS One 2013;8:e66858.
18. Lee CS, Kang EC, Lee KS, et al. Central serous chorioretinopathy after renal transplantation. Retina 2011;31:1896-1903.
19. Caccavale A, Romanazzi F, Imparato M, et al. Central serous chorioretinopathy: a pathogenetic model. Clin Ophthalmol 2011;5:239-243.
20. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999;19:508-512.
21. Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 2003;87:709-712.
22. Hu CC, Ho JD, Lin HC. Retinal vein occlusion and the risk of acute myocardial infarction: a 3-year follow-up study. Br J Ophthalmol 2009;93:717-720.
23. Chou KT, Huang CC, Tsai DC, et al. Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese. Am J Ophthalmol 2012;154:200-205.e1.
24. Hu CC, Ho JD, Lin HC. Neovascular age-related macular degeneration and the risk of stroke: a 5-year populationbased follow-up study. Stroke 2010;41:613-617.
25. Tsai DC, Huang CC, Chen SJ, et al. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study. Br J Ophthalmol 2012;96:1484-1488.
26. Tsai DC, Huang CC, Chen SJ, et al. Increased risk of erectile dysfunction among males with central serous chorioretinopathy- a retrospective cohort study. Acta Ophthalmol 2013;91: 666-671.